| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$1,798,117 ) |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 5 | NIH | 11/13/2024 | $0 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 001 | 1 | NIH | 3/24/2025 | -$353,512 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 5 | NIH | 2/28/2025 | -$167,853 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 003 | 4 | NIH | 2/14/2025 | $703,599 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 001 | 2 | NIH | 2/28/2025 | -$1 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 000 | 5 | NIH | 3/20/2025 | -$84,749 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 04 | 13 | HRSA | 10/29/2024 | -$366,137 |
| | 2025 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 03 | 13 | HRSA | 10/17/2024 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 003 | 1 | NIH | 2/12/2025 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 002 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 001 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 000 | 1 | NIH | 2/28/2025 | -$86,273 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 002 | 4 | NIH | 2/28/2025 | -$1,141 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 001 | 4 | NIH | 2/28/2025 | -$28,157 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA287457 | Does Tobacco Social Media Marketing Alter Adolescent Risk Perceptions and Use? Longitudinal Data-Adaptive Estimators and Causal Inference to Enhance Understanding | 001 | 1 | NIH | 2/28/2025 | -$38,007 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U2CCA271894 | Virginia-UCLA-Toronto Biomarker Characterization Center | 001 | 2 | NIH | 3/3/2025 | -$569,990 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R33AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 001 | 5 | NIH | 2/24/2025 | -$50,410 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01DA054826 | Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | 000 | 3 | NIH | 4/1/2025 | -$325,333 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151616 | Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension | 000 | 4 | NIH | 4/1/2025 | -$6,052 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL150014 | Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes | 000 | 4 | NIH | 4/1/2025 | -$21,718 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 004 | 1 | NIH | 2/12/2025 | $0 |
| | 2025 | 2023 | Old Dominion University | 735 Fairfax Ave Ste 909 | Norfolk | VA | 23507-2007 | NORFOLK CITY | USA | E3626086 | LDS - Allopathic Medicine | 001 | 3 | HRSA | 10/3/2024 | $0 |
| | 2025 | 2022 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21ES033007 | Cannabinoid-2 receptor signaling in vesicant induced lung injury | 000 | 2 | NIH | 1/3/2025 | -$8,011 |
| | 2025 | 2022 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U2CCA271894 | Virginia-UCLA-Toronto Biomarker Characterization Center | 000 | 1 | NIH | 3/3/2025 | -$8,080 |
| | 2025 | 2022 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R33AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 000 | 4 | NIH | 2/24/2025 | -$331,040 |
| | 2025 | 2022 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 3 | NIH | 12/12/2024 | -$28,670 |
| | 2025 | 2020 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01AG050567 | Histone H4 Lysine16 Acetylation in Aging and Lung Fibrosis | 000 | 6 | NIH | 10/27/2024 | -$26,582 |
|
| Issue Date FY: 2024 ( Subtotal = -$1,954,835 ) (Continued on the next page) |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 001 | 5 | NIH | 5/2/2024 | $21,899 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 001 | 5 | NIH | 6/28/2024 | -$196,067 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 5 | NIH | 6/3/2024 | $363,920 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 001 | 1 | NIH | 6/27/2024 | -$245,667 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 000 | 1 | NIH | 3/15/2024 | $645,992 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 001 | 5 | NIH | 6/28/2024 | -$95,240 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 5 | NIH | 12/6/2023 | $145,229 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 01 | 13 | HRSA | 6/3/2024 | $323,437 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 02 | 13 | HRSA | 8/2/2024 | $11,507 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 00 | 13 | HRSA | 3/13/2024 | $107,811 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 002 | 5 | NIH | 9/13/2024 | -$87,651 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 000 | 2 | NIH | 4/10/2024 | $166,547 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 001 | 2 | NIH | 9/13/2024 | -$166,546 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 000 | 5 | NIH | 2/15/2024 | $219,003 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 002 | 4 | NIH | 6/26/2024 | $34,801 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 003 | 4 | NIH | 6/28/2024 | -$95,543 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 001 | 4 | NIH | 1/29/2024 | $404,053 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 000 | 3 | NIH | 12/21/2023 | $510,187 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 002 | 3 | NIH | 6/27/2024 | -$150,980 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 001 | 3 | NIH | 6/12/2024 | $45,349 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21HD112742 | Designing effective RNA therapies for oocyte maturation | 000 | 1 | NIH | 9/13/2024 | -$303,504 |
|
